EP4580556A1 - Chirurgischer einsatz und knochenzement - Google Patents

Chirurgischer einsatz und knochenzement

Info

Publication number
EP4580556A1
EP4580556A1 EP23772554.4A EP23772554A EP4580556A1 EP 4580556 A1 EP4580556 A1 EP 4580556A1 EP 23772554 A EP23772554 A EP 23772554A EP 4580556 A1 EP4580556 A1 EP 4580556A1
Authority
EP
European Patent Office
Prior art keywords
layer
orifices
surgical insert
insert according
cement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23772554.4A
Other languages
English (en)
French (fr)
Inventor
Francine Monchau
Olivier CARPENTIER
Benoit GENESTIE
Nicolas Blanchemain
Gwenaël RAOUL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ecole Nationale Superieure Mines Telecom Lille Douai
Junia
Institut National de la Sante et de la Recherche Medicale INSERM
Centre Hospitalier Universitaire de Lille
Universite dArtois
Universite de Lille
Original Assignee
Ecole Nationale Superieure Mines Telecom Lille Douai
Junia
Institut National de la Sante et de la Recherche Medicale INSERM
Centre Hospitalier Universitaire de Lille
Universite dArtois
Universite de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR2208795A external-priority patent/FR3139276B1/fr
Priority claimed from FR2208793A external-priority patent/FR3139275B1/fr
Application filed by Ecole Nationale Superieure Mines Telecom Lille Douai, Junia, Institut National de la Sante et de la Recherche Medicale INSERM, Centre Hospitalier Universitaire de Lille, Universite dArtois, Universite de Lille filed Critical Ecole Nationale Superieure Mines Telecom Lille Douai
Publication of EP4580556A1 publication Critical patent/EP4580556A1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/56Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws or setting implements
    • A61B17/68Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • A61B17/80Cortical plates, i.e. bone plates; Instruments for holding or positioning cortical plates, or for compressing bones attached to cortical plates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/56Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B2017/561Implants with special means for releasing a drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30011Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in porosity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30062(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/3011Cross-sections or two-dimensional shapes
    • A61F2002/30112Rounded shapes, e.g. with rounded corners
    • A61F2002/3013Rounded shapes, e.g. with rounded corners figure-"8"- or hourglass-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/3092Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having an open-celled or open-pored structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2002/30971Laminates, i.e. layered products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • A61F2310/00293Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite

Definitions

  • the present disclosure relates to a surgical insert and a bone cement, in particular a surgical insert comprising a first layer and a second layer comprising octomorphic shaped orifices as well as a bone cement comprising a powdery solid phase comprising natural or derived polysaccharides of natural compounds and a ceramic filler and an acrylate in liquid phase.
  • a fracture of the orbital structure can also have aesthetic repercussions when it is associated with a fracture of the orbital rim, the nose or the zygomatic body by modifying the bony reliefs of the face.
  • the main objective of reconstructing the orbital structure is to reconstruct the shape and volume of the orbit specific to the anatomy of each patient.
  • reduction of thin bone fragments from the orbital floor is sometimes not sufficient or even impossible. It is therefore necessary to cover or fill the defect to avoid complications such as tissue displacement around the eye.
  • a biocompatible material also called an orbital implant
  • this orbital implant must be adapted to the anatomy of each patient in order to function optimally.
  • a material used as a bone substitute include: its biocompatibility, chemical and mechanical, its osteoconductivity, the capacity to allow the different cellular elements to reach the bone area to be repaired, its mechanical resistance which must be close to that of the bone and its macroporosity in order to allow the colonization of the cells and the revascularization of the graft.
  • a first material used is autologous bone.
  • Autologous bone is a sample of bone material from another part of the body such as the calvarium, the bone of the cranial vault, the iliac crest, one of the bones of the coxal bone, or the microvascularized bones in cases of extensive reconstructions. This material is useful for reconstruction and augmentation of the contours of the orbit, particularly after resection of a tumor using ionizing radiation treatment.
  • the bony parts cannot be of true anatomical shape and there appears a reduction in bone volume by bone resorption. It is also possible to use chondrocostal cartilage.
  • a second material that can be used is based on resorbable polymer membranes. They are ideal for small defects with a surface area of less than 1 cm 2 . However, for larger defects, resorbable polymer membranes do not have sufficient mechanical characteristics to support and stabilize the orbital walls.
  • a third commonly used material is titanium and its alloys. It has been used for around fifteen years and demonstrates excellent biocompatibility and excellent integration into the bone site. Titanium is a material with excellent corrosion resistance, a useful property knowing that the human body is particularly corrosive, as well as high mechanical resistance. It is easily shaped which makes it usable in many types of implants.
  • a therapeutic solution to bioceramics are bone substitutes in the form of cements.
  • the cement is less invasive, practical to handle and easily adapts to the volume to be treated.
  • the first family is that of phosphocalcic cements. They are mainly composed of calcium phosphate which gives them many advantages such as biocompatibility, bioresorption and bone regrowth properties. However, they have the drawback of being fragile and brittle.
  • the second family of cements is represented by acrylic cements. They are mainly made of polymethyl methacrylate, formed by polyaddition and used for fixing prostheses. They have good biocompatibility as well as excellent mechanical resistance. However, they have the drawback of having a withdrawal behavior after setting in situ, resulting in a void between the implant and the bone. This behavior can cause serious problems such as the loosening of certain prostheses.
  • a first type of implant is a manually shaped flat implant.
  • the surgeon uses replicas of the patient's skull sterilized in ABS (acrylonitrile butadiene styrene) to place and shape the implant to adapt it to the patient's anatomy.
  • ABS acrylonitrile butadiene styrene
  • This implant almost completely respects the patient's anatomy and thus improves the precision of surgical repairs.
  • this solution requires prerequisites: to be able to manufacture and sterilize the patient's skull in ABS, to desterilize and re-sterilize the implant, to have the time to carry out this operation and to be in a structure that has access to this technology. .
  • a second solution is to design implants for most individuals by anatomically preforming an implant covering the orbital floor and medial wall. These implants have “average” dimensions, that is to say, their dimensions are not specific to an individual but are suitable for the different anatomical shapes of the orbit. These implants are available in two different sizes. They allowed a clear improvement compared to standard implants.
  • a surgical insert comprising:
  • first layer and the second layer comprise orifices having an octomorphic shape.
  • the surgical insert according to the first aspect of the invention has an internal architecture optimized for better circulation of fluids and bone regrowth.
  • the first layer and the second layer ensure that the surgical insert has sufficient mechanical support properties, in particular by a significant reduction in maximum stresses.
  • This surgical insert can be used as a bone substitute, particularly for human or veterinary use. Its general form can be adapted to result in an anatomically shaped bone implant. Thus, it could be used, for example, to replace a part of the skeleton such as the orbital floor, serve as an osteosynthesis plate or form a joint prosthesis.
  • This surgical insert, or surgical implant can also be used for human or animal surgery, in particular vertebrates. It can be implanted or replace all or part of the structures of the human or animal body, for example a limb, the skull, the trunk, etc. It can be used in particular in reconstructive surgery of the limbs (lower and upper), the face (including the jaws, teeth) or the trunk (for example the spine). It can also be used in vascular, abdominal or digestive surgery.
  • a bone substitute is proposed in the form of bone cement (also called bone cement) comprising:
  • the bone cement according to the second aspect of the invention has advantageous properties, in particular excellent biocompatibility with the human body, excellent osteo-conductivity and mechanical strength close to that of human bone. It also has a macroporosity property allowing the colonization of cells and the revascularization of the graft.
  • FIG. 4 schematically shows a top view of octomorphic shaped orifices arranged in a hexagonal pattern
  • FIG. 7 schematically shows a top view of an example of a surgical insert according to the invention, of round shape
  • FIG. 9 shows the two sides of an example of a surgical insert according to the invention.
  • FIG. 10a schematically shows a top view of a first layer of a surgical insert according to the invention
  • FIG. 10b schematically shows a top view of a second layer of the same surgical insert as Figure 10a;
  • FIG. 11 schematically shows an example of a surgical insert according to the invention, in three dimensions comprising two layers separated from each other by a plurality of separators;
  • FIG. 12 schematically shows an example of a pillar with a straight longitudinal axis and perpendicular to the mean plane of the first or second layer;
  • FIG. 13 shows the evolution of the weighting coefficient C 2 as a function of the twist angle 0 of the pillars of the surgical insert according to the invention
  • FIG. 14 schematically shows an example of a pillar with a vertical longitudinal axis of helical shape with a twist angle different from 0;
  • FIG. 15 shows the evolution of the weighting coefficient C 3 as a function of the angle of inclination Q of the straight pillars of the surgical insert according to the invention
  • FIG. 16 schematically shows an example of a pillar with a longitudinal axis having a non-zero angle of inclination Q relative to the vertical;
  • FIG. 18 schematically shows an example of a pillar with a right longitudinal axis of helical shape having pores at its lateral surface
  • FIG. 19 schematically shows an example of a section of a layer of the surgical insert according to the invention and having an orifice of octomorphic shape and transverse orifices of octomorphic shape;
  • FIG. 20 schematically shows an example of a surgical insert according to the invention, in three dimensions having three layers separated by a plurality of pillars of vertical longitudinal axis of helical shape having pores at its lateral surface;
  • FIG. 21 shows an example of a Bézier curve or function
  • FIG. 22 shows a distribution of octomorphic shaped orifices along a Bézier curve
  • FIG. 23 is an enlargement of part of the Bézier curve of Figure 22 at an extremum
  • FIG. 24 shows overlapping sections induced by a homothetic duplication of the first layer leading to the second layer
  • FIG. 25 shows octomorphic orifices arranged in a partial rectangular pattern
  • FIG. 26 shows octomorphic orifices arranged partially along the contours of an octagon
  • FIG. 27 shows an example of a surgical insert according to the invention and its limit box
  • FIG. 28 shows the simulation results of two inserts both having octomorphic shaped orifices, one having mechanical reinforcement, the other being free;
  • FIG. 29 shows the ternary diagram of variation of the cellulose acetate, the ceramic filler and the starch included in the bone cement according to the invention
  • FIG. 30 shows the evolution of the Young modulus in the field of study of bone cement according to the invention
  • FIG. 31 shows the evolution of the shear modulus in the field of study of bone cement according to the invention
  • FIG. 32 shows the evolution of swelling in the field of study of bone cement according to the invention
  • FIG. 33 shows the evolution of the temperature as a function of time for the three formulations of bone cement according to the invention
  • FIG. 34 shows the evolution of the setting time of an acrylic cement as a function of the mass proportion of vitamin C in the bone cement according to the invention
  • FIG. 35 shows the evolution of the maximum temperature reached of an acrylic cement as a function of the mass proportion of vitamin C of the bone cement according to the invention
  • FIG. 37 shows the evolution of the swelling of Example 2.2 of the bone cement according to the invention in different liquid media as a function of the number of days of immersion;
  • FIG. 38 shows the evolution of the swelling of Example 2.3 of the bone cement according to the invention in different liquid media as a function of the number of days of immersion;
  • FIG. 41 shows the cell survival rate as a function of each formulation of the bone cement according to the invention and two controls, a first based on 100% alumina, and the second based on tissue culture polystyrene (TCPS), a material constituting the culture plates;
  • TCPS tissue culture polystyrene
  • FIG. 42 shows the total quantities of ciprofloxacin (CFX) present in the different formulations of bone cement according to the invention.
  • the present invention relates, according to a first aspect, to a surgical insert which will be described below with reference to Figures 1 to 28.
  • the surgical insert 1 comprises:
  • first layer 11 and the second layer 12 comprise orifices 111, 121 having an octomorphic shape.
  • Figure 1 shows a top view diagram of an orifice 111, 121 of octomorphic shape.
  • length we understand a dimension taken in a direction extending between the two lobes, the direction corresponding in particular to one of the axes of symmetry if present.
  • width we mean a dimension perpendicular to the length.
  • the thickness of the surgical insert is understood as a distance between the two extreme faces of the insert in the direction of superposition of the layers. Unless otherwise indicated, we mean the average thickness on the insert. The distance between two orifices is taken between the centers of these orifices.
  • the total length, L o can be between 200 pm and 50 mm. In certain cases (for example for orbital floors), this length is preferably
  • the ratio of the total length, L o , to the total width, t o can be between
  • (ptot is the total porosity of the surgical insert 1
  • (pi is the porosity of the first layer 11
  • ⁇ p 2 is the porosity of the second layer 12
  • Si is the total surface of the first layer 11
  • S 2 is the total surface area of the second layer 12.
  • the porosity is the ratio between the surface area occupied by the octomorphic orifices and the total surface area of the layer.
  • the insert 1 has a total porosity greater than or equal to 0.6 and less than or equal to 0.93.
  • the insert 1 has a ratio between the total surface occupied by the orifices of a layer and the total surface of this layer greater than or equal to 0.09 and less than or equal to 0.92.
  • the ratio between the total surface occupied by the orifices of a layer and the total surface of this layer is greater than or equal to 0.111 and less than or equal to 0.923.
  • the L/h ratio is less than 4. Subsequently, the characteristics will be described in the case of an L/h ratio less than 4. Furthermore, the fluid flows are then generally complex.
  • the second layer 12 may have two zones, a first zone 122 with orifices 1221 having a first maximum length l_ 2 and a second zone 123 with second orifices 1231 having a second maximum length.
  • the ratio between the first maximum length l_ 3 and the second maximum length l_ 2 can be between 1.6 and 2, preferably between 1.7 and 1.9, preferably between 1.75 and
  • the arrangement of the octomorphic orifices 121 on the second layer 12 can correspond to a homothetic duplication of the arrangement of the orifices octomorphs 111 of the first layer 11. That is to say that the orifices undergo a translation and a rotation (duplication) then a homogeneous scaling (homothety).
  • This homothetic duplication can be described by the following formulas: with :
  • the homothetic duplication induces a minimum overlap section SR of 0.2 mm 2 between the orifice 111 of the first layer 11 and the orifice 121 of the second layer 12 which results from it (see figure 24) .
  • the covering is worth a maximum of a quarter of the surface of the orifice 111 of the first layer 11.
  • a plurality of separators 15 can be arranged between the first layer 11 and the second layer 12.
  • Each separator 15 can be in the form of a pillar 15.
  • Figure 11 shows a three-dimensional surgical insert comprising two layers separated from each other by a plurality of pillars of octomorphic section.
  • the pillar 15 may have a longitudinal axis.
  • This longitudinal axis can be straight (figures 12, 14 and 16) or curved (figure 17). When the longitudinal axis is straight, it can extend perpendicularly from the average plane formed by the first layer 11 or by the second layer 12. It can also be understood as forming a non-right angle with this average plane. When the longitudinal axis is curved, it follows the curve of a parametric equation between the first layer 11 and the second layer 12.
  • Each separator 15 among the plurality of separators 15 may have a cross section which has an octomorphic shape as described above.
  • pillar 15 can be obtained by translation of the octomorphic shape along the longitudinal axis ( Figures 12, 16).
  • the pillar 15 can be obtained by a combination of translation and rotation of the octomorphic shape along the longitudinal axis so as to give the lateral surface of the pillar 15 a helical shape (figure 14).
  • the number of rotations of the octomorphic shape between the first layer 11 and the second layer 12 can be 1 /4+k, 1 /2+k, 3 /4+k or 1 -ik, where k is a number greater than or equal to 0; for example 0, 1, 2, 3.
  • the number of rotations is 1 /4+k or 3 /4+k
  • the number of rotations is 1 /2+k or 1 -ik
  • the pillar 15 is chosen as being a pillar 15 of helical shape with a twist angle p
  • said angle p can be between 0 and 180°, preferably less than 90° .

Landscapes

  • Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Manufacturing & Machinery (AREA)
  • Prostheses (AREA)
EP23772554.4A 2022-09-01 2023-08-31 Chirurgischer einsatz und knochenzement Pending EP4580556A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR2208795A FR3139276B1 (fr) 2022-09-01 2022-09-01 Insert chirurgical et ciment osseux
FR2208793A FR3139275B1 (fr) 2022-09-01 2022-09-01 Insert chirurgical
PCT/FR2023/051318 WO2024047317A1 (fr) 2022-09-01 2023-08-31 Insert chirurgical et ciment osseux

Publications (1)

Publication Number Publication Date
EP4580556A1 true EP4580556A1 (de) 2025-07-09

Family

ID=88092842

Family Applications (2)

Application Number Title Priority Date Filing Date
EP23772307.7A Pending EP4580555A1 (de) 2022-09-01 2023-08-31 Chirurgischer einsatz
EP23772554.4A Pending EP4580556A1 (de) 2022-09-01 2023-08-31 Chirurgischer einsatz und knochenzement

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP23772307.7A Pending EP4580555A1 (de) 2022-09-01 2023-08-31 Chirurgischer einsatz

Country Status (3)

Country Link
EP (2) EP4580555A1 (de)
CA (2) CA3265826A1 (de)
WO (2) WO2024047317A1 (de)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3450920B2 (ja) * 1994-12-26 2003-09-29 京セラ株式会社 生体補綴部材の製造方法
US6905516B1 (en) * 1999-05-19 2005-06-14 Ecole Polytechnique Federale De Lausanne (Epfl) Calcium phosphate bone substitute
JP2003052804A (ja) * 2001-08-09 2003-02-25 Ichiro Ono インプラントの製造方法およびインプラント
WO2008095307A1 (en) * 2007-02-07 2008-08-14 Mcgill University Bioceramic implants having bioactive substance
US9398960B2 (en) * 2011-09-16 2016-07-26 Globus Medical, Inc. Multi-piece intervertebral implants
US20210338454A1 (en) * 2015-10-21 2021-11-04 Mca Group, Llc 3d printed osteogenesis scaffold
EP3416592B1 (de) * 2016-02-18 2022-12-21 Lifenet Health Knochentransplantat

Also Published As

Publication number Publication date
WO2024047318A1 (fr) 2024-03-07
WO2024047317A1 (fr) 2024-03-07
EP4580555A1 (de) 2025-07-09
CA3265826A1 (fr) 2024-03-07
CA3265881A1 (fr) 2024-03-07

Similar Documents

Publication Publication Date Title
Tytgat et al. Extrusion-based 3D printing of photo-crosslinkable gelatin and κ-carrageenan hydrogel blends for adipose tissue regeneration
Frazer et al. PMMA: an essential material in medicine and dentistry
FR2590175A1 (fr) Implants de collagene
Chichiricco et al. In situ photochemical crosslinking of hydrogel membrane for guided tissue regeneration
CN104812419B (zh) 选择性可聚合组合物及其活体内使用方法
Menikheim et al. Self‐healing biomaterials: The next generation is nano
CN100408112C (zh) 含双相钙磷颗粒的海藻酸钠交联明胶的可注射水凝胶及其制备方法和应用
NL1032851C2 (nl) Kit en werkwijze voor het fixeren van een prothese of deel daarvan en/of het vullen van benige defecten.
Kang et al. Microstructures and biological properties of 3D-printed titanium intervertebral spacer with the tri-calcium phosphate loaded demineralized bone matrix hydrogel
JP7522309B2 (ja) 高弾性のリン酸カルシウム系注入型骨移植材組成物及びその製造方法
EP2307064B1 (de) Calciumphosphathaltige biomaterialien
Luss et al. Gel based on hydroxyethyl starch with immobilized Amikacin for coating of bone matrices in experimental osteomyelitis treatment
WO2024047317A1 (fr) Insert chirurgical et ciment osseux
Ming Kuo et al. Evaluating chitosan/β‐tricalcium phosphate/poly (methyl methacrylate) cement composites as bone‐repairing materials
FR3139276A1 (fr) Insert chirurgical et ciment osseux
Tang et al. Study on synergistic effects of Nanohydroxyapatite/High-Viscosity carboxymethyl cellulose scaffolds stimulated by LIPUS for bone defect repair of rats
FR2876917A1 (fr) Composition de comblement osseux
Woo et al. Biomaterials: Historical overview and current directions
Bojar et al. Novel chitosan-based bone substitute
KR20230022392A (ko) 유무기 복합 하이드로겔 제조용 조성물 및 이를 포함하는 유무기 복합 하이드로겔 제조용 키트
Kothawade et al. Polymers in Modern Medicine (Part 1)
Bedse et al. Polymeric Implants and Prosthetics
Wang et al. A novel in-situ hybrid-crosslinked oxidized hyaluronic acid/Gel-MA hydrogel membrane with significantly enhanced mechanical and osteogenic properties for guided bone regeneration
FR3139275A1 (fr) Insert chirurgical
Sonowal et al. 2 History of Calcium

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20250320

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)